SS-31 inhibits mtDNA–cGAS–STING signaling to improve POCD by activating mitophagy in aged mice
Inflammation Research · 2024-04 · 73 (4) · 641-654
DOI: 10.1007/s00011-024-01860-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation Research, online erschienen am 27.02.2024. Verfasst von Yelong Ji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, China. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Mitophagy, Postoperative Cognitive Complications. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Shanghai Municipal Key Clinical Specialty, the research program of Zhongshan Hospital, Fudan University.
Abstract (Originalsprache)
BACKGROUND: Neuroinflammation is crucial in the development of postoperative cognitive dysfunction (POCD), and microglial activation is an active participant in this process. SS-31, a mitochondrion-targeted antioxidant, is widely regarded as a potential drug for neurodegenerative diseases and inflammatory diseases. In this study, we sought to explore whether SS-31 plays a neuroprotective role and the underlying mechanism. METHODS: Internal fixation of tibial fracture was performed in 18-month-old mice to induce surgery-associated neurocognitive dysfunction. LPS was administrated to BV2 cells to induce neuroinflammation. Neurobehavioral deficits, hippocampal injury, protein expression, mitophagy level and cell state were evaluated after treatment with SS-31, PHB2 siRNA and an STING agonist. RESULTS: Our study revealed that SS-31 interacted with PHB2 to activate mitophagy and improve neural damage in surgically aged mice, which was attributed to the reduced cGAS-STING pathway and M1 microglial polarization by decreased release of mitochondrial DNA (mtDNA) but not nuclear DNA (nDNA). In vitro, knockdown of PHB2 and an STING agonist abolished the protective effect of SS-31. CONCLUSIONS: SS-31 conferred neuroprotection against POCD by promoting PHB2-mediated mitophagy activation to inhibit mtDNA release, which in turn suppressed the cGAS-STING pathway and M1 microglial polarization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, China.
- Department of Anesthesia, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, China. ge.shengjin@fudan.edu.cn.
Förderung
- Shanghai Municipal Key Clinical Specialty
- the research program of Zhongshan Hospital, Fudan University
Zitieren
APA
Ji, Y., Ma, Y., Ma, Y., Wang, Y., Zhao, X., Jin, D., Xu, L., & Ge, S. (2024). SS-31 inhibits mtDNA–cGAS–STING signaling to improve POCD by activating mitophagy in aged mice. Inflammation Research, 73(4), 641-654. https://doi.org/10.1007/s00011-024-01860-1
Vancouver
Ji Y, Ma Y, Ma Y, Wang Y, Zhao X, Jin D, et al. SS-31 inhibits mtDNA–cGAS–STING signaling to improve POCD by activating mitophagy in aged mice. Inflammation Research. 2024;73(4):641-654. doi:10.1007/s00011-024-01860-1
BibTeX
@article{Ji2024,
author = {Ji, Yelong and Ma, Yuanyuan and Ma, Yimei and Wang, Ying and Zhao, Xining and Jin, Danfeng and Xu, Li and Ge, Shengjin},
title = {SS-31 inhibits mtDNA–cGAS–STING signaling to improve POCD by activating mitophagy in aged mice},
journal = {Inflammation Research},
year = {2024},
volume = {73},
number = {4},
pages = {641--654},
doi = {10.1007/s00011-024-01860-1}
}
EUVIMED